KD Logo

The Attractiveness of Investing In Adc Therapeutics SA (ADCT) is Growing

Adc Therapeutics SA’s recently made public that its 10% Owner Redmile Group, LLC acquired Company’s shares for reported $0.3 million on Dec 11 ’24. In the deal valued at $3.04 per share,100,000 shares were bought. As a result of this transaction, Redmile Group, LLC now holds 15,666,731 shares worth roughly $24.75 million.

Then, Redmile Group, LLC bought 100,000 shares, generating $304,500 in total proceeds. Upon buying the shares at $3.04, the 10% Owner now owns 13,145,712 shares.

Before that, Redmile Group, LLC sold 25,352 shares. Adc Therapeutics SA shares valued at $52,479 were divested by the 10% Owner at a price of $2.07 per share. As a result of the transaction, Redmile Group, LLC now holds 15,566,731 shares, worth roughly $24.6 million.

Stephens initiated its Adc Therapeutics SA [ADCT] rating to an Overweight in a research note published on November 08, 2024; the price target was $6. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late May with a ‘”an Overweight”‘ rating. Guggenheim began covering ADCT with “Buy” recommendation on March 28, 2024. JP Morgan revised its rating on August 10, 2023. It rated ADCT as “a Neutral” which previously was an “an Underweight”.

Price Performance Review of ADCT

On Monday, Adc Therapeutics SA [NYSE:ADCT] saw its stock fall -5.95% to $1.58. Over the last five days, the stock has lost -5.95%. Adc Therapeutics SA shares have fallen nearly -20.60% since the year began. Nevertheless, the stocks have fallen -49.36% over the past one year. While a 52-week high of $6.04 was reached on 01/02/25, a 52-week low of $1.59 was recorded on 02/03/25. SMA at 50 days reached $2.0188, while 200 days put it at $3.0096.

Levels Of Support And Resistance For ADCT Stock

The 24-hour chart illustrates a support level at 1.5367, which if violated will result in even more drops to 1.4933. On the upside, there is a resistance level at 1.6467. A further resistance level may holdings at 1.7133. The Relative Strength Index (RSI) on the 14-day chart is 38.02, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0607, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.55%. Stochastics %K at 26.69% indicates the stock is a holding.

How much short interest is there in Adc Therapeutics SA?

A steep rise in short interest was recorded in Adc Therapeutics SA stocks on 2025-01-15, growing by 1.06 million shares to a total of 5.18 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 4.12 million shares. There was a rise of 20.39%, which implies that there is a positive sentiment for the stock.

Most Popular